In August, the U.S. Food and Drug Administration approved the new COVID-19 booster shots, but with certain restrictions.

A U.S. Centers for Disease Control and Prevention (CDC) advisory panel will meet on Friday to review data on the COVID-19 vaccine developed by Pfizer Inc and BioNTech SE, with a vote expected on ...

An AI agent is a software program that can interact with this environment, collect data and then use that information to ...

The issue goes beyond Trump’s hyperbolic talk to his belief that the brute force of tariffs and shaming of companies can deliver economic results.

Pfizer Inc's Chief Executive Officer Albert Bourla said on Tuesday the company would never discuss the U.S. Food and Drug Administration's guidelines on coronavirus vaccines with the White House as it ...

Pfizer Inc. remains attractive with strong fundamentals, cost control, an expanding market, and new drugs. Click here to read ...

WASHINGTON, DC - SEPTEMBER 30: Pfizer CEO Albert Bourla speaks shakes hands with U.S. President Donald Trump as Centers for Medicare & Medicaid Services Mehmet Oz looks on after Trump announced a deal ...

Nikki Battiste is a CBS News national correspondent based in New York. She is an Emmy and Peabody-award winning journalist, and her reporting appears across all CBS News broadcasts and platforms.

Drugmaker Pfizer has agreed to lower drug costs and invest $70 billion in U.S. manufacturing under a deal struck with the Trump administration, President Donald Trump said Tuesday.The announcement, ...

As Pfizer and other pharma giants faced a Monday deadline under President Donald Trump's "most favored nation" (MFN) drug pricing campaign, the world is now getting some clarity on what the ...

US pharmaceutical giant Pfizer will acquire Metsera, a maker of drugs for obesity and heart disease, for $4.9 billion, the companies said Monday. With the purchase Pfizer aims to expand its portfolio ...